Bidirectional Regulatory Cross-Talk between Cell Context and Genomic Aberrations Shapes Breast Tumorigenesis.


Journal

Molecular cancer research : MCR
ISSN: 1557-3125
Titre abrégé: Mol Cancer Res
Pays: United States
ID NLM: 101150042

Informations de publication

Date de publication:
11 2021
Historique:
received: 05 03 2021
revised: 02 06 2021
accepted: 16 07 2021
pubmed: 22 7 2021
medline: 23 3 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

Breast cancers are classified into five intrinsic subtypes and 10 integrative clusters based on gene expression patterns and genomic aberrations, respectively. Although the cell-of-origin, adaptive plasticity, and genomic aberrations shape dynamic transcriptomic landscape during cancer progression, how interplay between these three core elements governs obligatory steps for a productive cancer progression is unknown. Here, we used genetic ancestry-mapped immortalized breast epithelial cell lines generated from breast biopsies of healthy women that share gene expression profiles of luminal A, normal-like, and basal-like intrinsic subtypes of breast cancers and breast cancer relevant oncogenes to develop breast cancer progression model. Using flow cytometry, mammosphere growth, signaling pathway, DNA damage response, and

Identifiants

pubmed: 34285086
pii: 1541-7786.MCR-21-0163
doi: 10.1158/1541-7786.MCR-21-0163
pmc: PMC8568628
mid: NIHMS1728184
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

1802-1817

Subventions

Organisme : NCI NIH HHS
ID : P30 CA082709
Pays : United States

Informations de copyright

©2021 American Association for Cancer Research.

Références

Genes Dev. 2001 Jan 1;15(1):50-65
pubmed: 11156605
NPJ Breast Cancer. 2019 Sep 9;5:30
pubmed: 31531391
Nat Commun. 2016 Jan 29;7:10478
pubmed: 26823093
Mol Cancer Res. 2019 Jul;17(7):1556-1570
pubmed: 30992305
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
Cancer Discov. 2020 Aug;10(8):1174-1193
pubmed: 32404308
Sci Transl Med. 2012 Mar 28;4(127):127ps10
pubmed: 22461637
Nature. 2015 Jan 1;517(7532):81-4
pubmed: 25327250
Genes Dev. 2014 Jun 1;28(11):1143-58
pubmed: 24888586
Nat Med. 2009 Aug;15(8):907-13
pubmed: 19648928
Nature. 2015 Oct 1;526(7571):131-5
pubmed: 26416748
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6124-9
pubmed: 22454501
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2772-7
pubmed: 21940501
Cell Rep Med. 2021 Mar 16;2(3):100219
pubmed: 33763657
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
Mol Cell Biol. 2002 Apr;22(7):2111-23
pubmed: 11884599
NPJ Breast Cancer. 2021 Feb 8;7(1):10
pubmed: 33558495
Sci Rep. 2015 Aug 27;5:13526
pubmed: 26311223
Oncogene. 2000 Feb 21;19(8):968-88
pubmed: 10713680
Nat Cell Biol. 2017 Mar;19(3):164-176
pubmed: 28192422
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Breast Cancer Res. 2010;12(5):R87
pubmed: 20964822
Cancer Res. 2011 Apr 15;71(8):3121-31
pubmed: 21389092
Breast Cancer Res. 2005;7(4):171-9
pubmed: 15987472
Am J Pathol. 2003 Dec;163(6):2531-41
pubmed: 14633625
Cancers (Basel). 2019 Sep 19;11(9):
pubmed: 31546901
Nature. 2015 Dec 10;528(7581):267-71
pubmed: 26633636
Environ Mol Mutagen. 2015 Jul;56(6):491-504
pubmed: 25773265
Cancer Res. 2015 Nov 15;75(22):4960-72
pubmed: 26400062
Breast Cancer Res Treat. 2012 May;133(1):169-77
pubmed: 21881938
Cancer Res. 2018 Sep 1;78(17):5107-5123
pubmed: 29997232
Cell Stem Cell. 2019 Jan 3;24(1):65-78
pubmed: 30554963
Cell Rep. 2014 Jan 16;6(1):117-29
pubmed: 24373972
Nat Med. 2009 Aug;15(8):842-4
pubmed: 19661985
Breast Cancer Res Treat. 2020 Feb;180(1):87-95
pubmed: 31970558
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
Cell Stem Cell. 2011 Feb 4;8(2):149-63
pubmed: 21295272
Oncogene. 2002 Mar 27;21(13):2066-78
pubmed: 11960379
Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4158-63
pubmed: 15020770
Cold Spring Harb Symp Quant Biol. 2016;81:123-129
pubmed: 28062533
Pharmacol Res. 2018 Mar;129:156-176
pubmed: 29154989
Leukemia. 2010 Apr;24(4):679-86
pubmed: 20130602
Oncogene. 2005 Nov 21;24(52):7729-45
pubmed: 16299533
Clin Cancer Res. 2019 May 1;25(9):2848-2859
pubmed: 30718355
Cancer Cell. 2007 Aug;12(2):160-70
pubmed: 17692807
Cancer Res. 2007 Sep 1;67(17):8065-80
pubmed: 17804718

Auteurs

Brijesh Kumar (B)

Departments of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Poornima Bhat-Nakshatri (P)

Departments of Surgery, Indiana University School of Medicine, Indianapolis, Indiana.

Calli Maguire (C)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Max Jacobsen (M)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Constance J Temm (CJ)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

George Sandusky (G)

Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana.

Harikrishna Nakshatri (H)

Departments of Surgery, Indiana University School of Medicine, Indianapolis, Indiana. hnakshat@iupui.edu.
Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana.
Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH